Hypermarcas (OTCMKTS:HYPMY) Short Interest Up 1,055.6% in August

Key Points

• Hypermarcas reported a staggering 1,055.6% increase in short interest for August, with total short interest reaching 10,400 shares.
• The company's stock price rose by 3.1% to $4.37, despite a lower trading volume compared to its average.
• Hypermarcas announced a dividend of $0.0345 per share, equating to a dividend yield of 281.0%, payable on January 8th for record holders as of July 1st.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) was the recipient of a significant growth in short interest in August. As of August 15th, there was short interest totaling 10,400 shares, agrowthof1,055.6% from the July 31st total of 900 shares. Based on an average daily volume of 160,800 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 160,800 shares, the short-interest ratio is currently 0.1 days.

Hypermarcas Stock Up 3.1%

HYPMY stock traded up $0.13 during trading hours on Tuesday, hitting $4.37. The company's stock had a trading volume of 2,366 shares, compared to its average volume of 73,355. The company has a quick ratio of 0.80, a current ratio of 1.26 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $2.77 billion, a PE ratio of 20.81 and a beta of 0.86. Hypermarcas has a 12 month low of $2.64 and a 12 month high of $5.36. The stock has a 50 day moving average price of $4.60 and a two-hundred day moving average price of $4.10.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.12 EPS for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Dividend Announcement

The company also recently disclosed a dividend, which will be paid on Friday, January 8th. Stockholders of record on Tuesday, July 1st will be paid a $0.0345 dividend. This represents a dividend yield of 281.0%. The ex-dividend date is Monday, June 30th. Hypermarcas's payout ratio is presently 57.14%.

Analyst Ratings Changes

Separately, Scotiabank raised shares of Hypermarcas to a "strong-buy" rating in a research report on Thursday, July 17th. One analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the company has a consensus rating of "Strong Buy".

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.